Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (263)	6/25/1999 9:15:00 AM
From: LLCF	Read Replies (2) \| Respond to of 805

Time to repeat this: Message 9686199 And this by Rick: "I'm not much of an encapsulation fan." Message 9703286 Nice call Rick. Company says: "The Company plans to continue to aggressively pursue research, development and commercialization of its broad, proprietary stem/progenitor cell technology platforms. CytoTherapeutics' patent estate covering its stem cell technology consists of 10 issued US patents and 28 US patent applications." Well, they have about 1 years worth of cash left they BETTER be agressive! Into the clinic next week, P1 in Sept., P2 in Jan and a partner in the 1st quarter??? Yea, thats the ticket... DAK